Variability of intestinal colonization with third-generation cephalosporin-resistant Enterobacteriaceae and antibiotic use in intensive care units

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 6, 2012, Pages 1525-1536

  Thiébaut, Anne C M ^a,c   Arlet, Guillaume ^d,e   Andremont, Antoine ^f,g   Papy, Emmanuelle ^f,g   Sollet, Jean Pierre ^h   Berne'de Bauduin, Claire ^a,b,k   Guillemot, Didier ^a,b,c,i   Schlemmer, Benoit ^g,j   Donay, Jean Luc ^j   Thiéry, Guillaume ^j   Le Turdu, Françoise ^h   Garrouste Orgeas, Maité ^l   Kitzis, Marie Dominique ^l   Troché, Gilles ^m   Billon, Catherine ^m   Cohen, Yves ⁿ   Soileux, Marc ⁿ   Paugam Burtz, Catherine ^o   Leflon Guibout, Véronique ^o   Armand Lefebvre, Laurence ^f   Lasocki, Sigismond ^f   Montravers, Philippe ^f   Pajot, Olivier ^f   Skurnik, David ^f   Ricard, Jean Damien ^p   Barnaud, Guilène ^p   Fartoukh, Muriel ^d   Cavelot, Sébastien ^d   Delisle, Françoise ^d   Tonéatti, Christine ^b   Bernède Bauduin, Claire ^b   Douay, Caroline ^b   Richard, Jean Romain ^b   Rault, Caroline ^b   Eurin, Mathilde ^b   Thiébaut, Anne ^b   more..

^a INSERM   (France)

^b INSTITUT PASTEUR   (France)

^c University Versailles Saint Quentin UVSQ   (France)

^d HÔPITAL TENON   (France)

^e SORBONNE UNIVERSITÉ   (France)

^f BICHAT HOSPITAL   (France)

^g UNIVERSITÉ PARIS DESCARTES   (France)

^h CENTRE HOSPITALIER VICTOR DUPOUY   (France)

ⁱ RAYMOND POINCARÉ HOSPITAL   (France)

^j SAINT LOUIS HOSPITAL   (France)

^k ORS Réunion   (France)

^l SAINT JOSEPH HOSPITAL   (France)

^m CENTRE HOSPITALIER DE VERSAILLES   (France)

ⁿ AVICENNE HOSPITAL   (France)

^o BEAUJON HOSPITAL   (France)

^p HÔPITAL LOUIS MOURIER   (France)

more..

Author keywords

Antibiotic resistance; Gut colonization; ICUs

Indexed keywords

CEPHALOSPORIN; EXTENDED SPECTRUM BETA LACTAMASE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; CEPHALOSPORIN RESISTANT ENTEROBACTERIACEAE; CROSS INFECTION; DRUG USE; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; IMMUNOCOMPROMISED PATIENT; INCIDENCE; INTENSIVE CARE; KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONHUMAN; OBSERVATIONAL STUDY; PRESCRIPTION; PROSPECTIVE STUDY;

EID: 84861181314     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks072     Document Type: Article

References (37)

1. Bradford PA. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001; 14: 933-51.
2. de Kraker MEA, Davey PG, Grundmann H et al. Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe. PLoS Med 2011; 8: e1001104.
3. Lautenbach E, Patel JB, Bilker WB et al. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 2001; 32: 1162-71.
4. Schwaber MJ, Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum β-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother 2007; 60: 913-20.
5. Vincent JL, Rello J, Marshall J et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009; 302: 2323-9.
6. de Kraker ME, Wolkewitz M, Davey PG et al. Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins. J Antimicrob Chemother 2011; 66: 398-407.
7. Réseau d'alerte, d'investigation et de surveillance des infections nosocomiales (Raisin). Enquête nationale de prévalence des infections nosocomiales, France, juin 2006. Saint-Maurice (France): Institut de Veille Sanitaire, 2009.
8. Réseau d'alerte, d'investigation et de surveillance des infections nosocomiales (Raisin). Surveillance des infections nosocomiales en réanimation adulte: Réseau REA-Raisin, France, résultats 2007. Saint-Maurice (France): Institut de Veille Sanitaire, 2009.
9. Lee SO, Lee ES, Park SY et al. Reduced use of third-generation cephalosporins decreases the acquisition of extended-spectrum β-lactamase-producing Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2004; 25: 832-7.
10. Wendt C, Lin D, von Baum H. Risk factors for colonization with third-generation cephalosporin-resistant Enterobacteriaceae. Infection 2005; 33: 327-32.
11. Rodríguez-Baño J, Navarro MD, Romero L et al. Clinical and molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli as a cause of nosocomial infection or colonization: implications for control. Clin Infect Dis 2006; 42: 37-45.
12. Hyle EP, Bilker WB, Gasink LB et al. Impact of different methods for describing the extent of prior antibiotic exposure on the association between antibiotic use and antibiotic-resistant infection. Infect Control Hosp Epidemiol 2007; 28: 647-54.
13. Nijssen S, Fluit A, van de Vijver D et al. Effects of reducing β-lactam antibiotic pressure on intestinal colonization of antibiotic-resistant gram-negative bacteria. Intensive Care Med 2010; 36: 512-9.
14. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Eighteenth Informational Supplement M100-S18. CLSI, Wayne, PA, USA, 2008.
15. Livermore DM. b-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995; 8: 557-84.
16. Verdet C, Benzerara Y, Gautier V et al. Emergence of DHA-1-producing Klebsiella spp. in the Parisian region: genetic organization of the ampC and ampR genes originating from Morganella morganii. Antimicrob Agents Chemother 2006; 50: 607-17.
17. Ruppé E, Hem S, Lath S et al. CTX-M β-lactamases in Escherichia coli from community-acquired urinary tract infections, Cambodia. Emerg Infect Dis 2009; 15: 741-8.
18. Eckert C, Gautier V, Saladin-Allard M et al. Dissemination of CTX-M-type β-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob Agents Chemother 2004; 48: 1249-55.
19. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270: 2957-63.
20. McCabe WR, Jackson GG. Gram negative bacteremia: I. Etiology and ecology. Arch Intern Med 1962; 110: 845-55.
21. Knaus WA, Zimmerman JE, Wagner DP et al. APACHE-acute physiology and chronic health evaluation: a physiologically based classification system. Crit Care Med 1981; 9: 591-7.
22. Vincent JL, de Mendonca A, Cantraine F et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med 1998; 26: 1793-800.
23. Teasdale G, Murray G, Parker L et al. Adding up the Glasgow Coma Score. Acta Neurochir Suppl (Wien) 1979; 28: 13-6.
24. Monnet DL, Frimodt-Moller N. Only percentage within species; neither incidence, nor prevalence: demographic information and representative surveillance data are urgently needed to estimate the burden of antimicrobial resistance (letter). Int J Antimicrob Agents 2004; 24: 622-3.
25. Réseau d'alerte, d'investigation et de surveillance des infections nosocomiales (Raisin). Surveillance des bactéries multirésistantes dans les établissements de santéen France: Réseau BMR-Raisin, Résultats 2007. Saint-Maurice (France): Institut de Veille Sanitaire, 2009.
26. Bouchillon SK, Johnson BM, Hoban DJ et al. Determining incidence of extended spectrum β-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001-2002. Int J Antimicrob Agents 2004; 24: 119-24.
27. Harris AD, McGregor JC, Johnson JA et al. Risk factors for colonization with extended-spectrum β-lactamase-producing bacteria and intensive care unit admission. Emerg Infect Dis 2007; 13: 1144-9.
28. Friedmann R, Raveh D, Zartzer E et al. Prospective evaluation of colonization with extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae among patients at hospital admission and of subsequent colonization with ESBL-producing Enterobacteriaceae among patients during hospitalization. Infect Control Hosp Epidemiol 2009; 30: 534-42.
29. Goossens H, Ferech M, Coenen S et al. Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries. Clin Infect Dis 2007; 44: 1091-5.
30. Vander Stichele RH, Elseviers MM, Ferech M et al. Hospital consumption of antibiotics in 15 European countries: results of the ESAC Retrospective Data Collection (1997-2002). J Antimicrob Chemother 2006; 58: 159-67.
31. Kuster SP, Ruef C, Bollinger AK et al. Correlation between case mix index and antibiotic use in hospitals. J Antimicrob Chemother 2008; 62: 837-42.
32. Shalit I, Low M, Levy E et al. Antibiotic use in 26 departments of internal medicine in 6 general hospitals in Israel: variability and contributing factors. J Antimicrob Chemother 2008; 62: 196-204.
33. Pitout JD, Laupland KB. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008; 8: 159-66.
34. Rice LB, Eckstein EC, DeVente J et al. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center. Clin Infect Dis 1996; 23: 118-24.
35. Leibovici L, Berger R, Gruenewald T et al. Departmental consumption of antibiotic drugs and subsequent resistance: a quantitative link. J Antimicrob Chemother 2001; 48: 535-40.
36. Iosifidis E, Antachopoulos C, Tsivitanidou M et al. Differential correlation between rates of antimicrobial drug consumption and prevalence of antimicrobial resistance in a tertiary care hospital in Greece. Infect Control Hosp Epidemiol 2008; 29: 615-22.
37. Harbarth S, Harris AD, Carmeli Y et al. Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli. Clin Infect Dis 2001; 33: 1462-8.